New diabetes clinical trial: Wharton´s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed With Type I Diabetes

Published on: June 04, 2019 at 09:30PM
Condition:   Type1diabetes
Intervention:   Drug: ProTrans
Sponsor:   NextCell Pharma Ab
Recruiting
http://bit.ly/2WnbPGt